KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EBITDA: 2009-2025

Historic EBITDA for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to $1.9 billion.

  • Thermo Fisher Scientific's EBITDA rose 5.60% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 4.63%. This contributed to the annual value of $7.3 billion for FY2024, which is 6.97% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported EBITDA of $1.9 billion as of Q3 2025, which was up 5.83% from $1.8 billion recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's EBITDA peaked at $3.0 billion during Q2 2021, and registered a low of $1.6 billion during Q2 2023.
  • For the 3-year period, Thermo Fisher Scientific's EBITDA averaged around $1.8 billion, with its median value being $1.8 billion (2025).
  • In the last 5 years, Thermo Fisher Scientific's EBITDA soared by 236.53% in 2021 and then crashed by 44.59% in 2023.
  • Thermo Fisher Scientific's EBITDA (Quarterly) stood at $2.5 billion in 2021, then decreased by 26.67% to $1.9 billion in 2022, then fell by 0.38% to $1.9 billion in 2023, then climbed by 8.74% to $2.0 billion in 2024, then grew by 5.60% to $1.9 billion in 2025.
  • Its EBITDA stands at $1.9 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.7 billion for Q1 2025.